Submitted by Anonymous (not verified) on 18 April 2024 - 14:15
Human medicines European public assessment report (EPAR): Ayvakyt, avapritinib, Date of authorisation: 24/09/2020, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ayvakyt, avapritinib, Date of authorisation: 24/09/2020, Revision: 9, Status: Authorised